Table 2 Characteristics of non-starting patients and early withdrawn patients

N

%

N

%

Sex

Male

50

79

39

67

0.131

Female

13

21

19

33

Tumour location

Lung

21

33

13

22

0.045

Rectum

4

6

15

26

Skin

5

8

9

16

Other

33

52

21

36

Metastasis

Yes

16

25

25

43

0.04

No

47

75

33

57

Palliative

Yes

19

30

27

47

0.063

No

44

70

31

53

Concomitant chemotherapy

Yes

21

33

25

43

0.269

No

42

67

33

57

Ambulance

Yes

30

48

40

69

0.022

No

32

52

18

31

Inpatient

Yes

12

19

21

36

0.034

No

51

81

37

64

Reason for withdrawal

Death due to tumour progression

17

27

18

31

Clinical progression

8

13

15

26

Non-oncology reasons

6

10

11

19

0.001

Toxicity

2

3

8

14

Patient refusal

10

16

2

3

Dosimetric issues

5

8

0

0

Other

15

24

4

7